Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Markus W. Sieger departed as director at Cyclo Therapeutics, Inc..
- Action
- ceased
- Role
- director
Exact text from the filing
Markus W. Sieger, a former director of the Company, was appointed to the board of directors of Rafael.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Cyclo Therapeutics, Inc. underwent a change of control involving Rafael Holdings, Inc. (closed 2025-03-25).
- Action
- change of control
- Counterparty
- Rafael Holdings, Inc.
- Closing
- 2025-03-25
Exact text from the filing
On March 25, 2025, Cyclo Therapeutics, Inc., a Nevada corporation (the "Company"), completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of August 21, 2024, as amended as of December 18, 2024 and February 4, 2025, by and among the Company, Rafael Holdings, Inc. ("Rafael"), Tandem Therapeutics, Inc., a wholly owned subsidiary of Rafael ("First Merger Sub"), and Tandem Therapeutics, LLC, a wholly owned subsidiary of Rafael ("Second Merger Sub", and together with First Merger Sub, "Merger Subs") (the "Merger Agreement"), pursuant to which: (i) First Merger Sub merged with and into the Company (the "First Merger"), causing First Merger Sub to cease to exist and the Company to become a wholly owned subsidiary of Rafael
View on SEC.gov